A phase IB study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma

被引：0
|
作者：
Hong, David S.
Andresen, Corina
Mink, Jennifer
Ren, Min
O'Brien, James P.
Ly Minh Nguyen
Falchook, Gerald Steven
Kurzrock, Razelle
Nemunaitis, John J.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Eisai & Co Ltd, Woodcliff Lake, NJ USA
[3] Mary Crowley Canc Res Ctr, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8594
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma
    Hong, David S.
    Kurzrock, Razelle
    Falchook, Gerald S.
    Andresen, Corina
    Kwak, Jennifer
    Ren, Min
    Xu, Lucy
    George, Goldy C.
    Kim, Kevin B.
    Nguyen, Ly M.
    O'Brien, James P.
    Nemunaitis, John
    ONCOTARGET, 2015, 6 (40) : 43127 - 43134
  • [2] Treatment of advanced solid tumors with golvatinib (E7050) in combination with lenvatinib (E7080)
    Kwak, E. L.
    Juric, D.
    Cleary, J. M.
    Cote, G.
    Hilton, J. F.
    Flaherty, K. T.
    Wood, K.
    Rance, C.
    Barrett, S.
    Shapiro, G. I.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 158 - 158
  • [3] A PHASE IB CLINICAL TRIAL OF THE MULTITARGETED KINASE INHIBITOR LENVATINIB (E7080) IN COMBINATION WITH EVEROLIMUS FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA (RCC)
    Molina, A. M.
    Hutson, T. E.
    Larkin, J.
    Gold, A.
    Andresen, C.
    Wood, K.
    Motzer, R. J.
    Michaelson, M. D.
    ANNALS OF ONCOLOGY, 2012, 23 : 269 - 269
  • [4] A phase Ib clinical trial of the multitargeted kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
    Molina, Ana M.
    Hutson, Thomas E.
    Larkin, James M. G.
    Gold, Anne
    Andresen, Corina
    Wood, Karen
    Motzer, Robert John
    Michaelson, M. Dror
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [5] A PHASE I AND DOSE-FINDING STUDY OF LENVATINIB (E7080) IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Yamamoto, N.
    Nokihara, H.
    Yamada, Y.
    Honda, K.
    Wakui, H.
    Sasaki, T.
    Yusa, W.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [6] A phase I study of E7080 in patients (pts) with advanced malignancies
    Glen, H.
    Boss, D. R.
    Morrison, R.
    Roelvink, M.
    Wanders, J.
    Mazur, A.
    Gupta, A.
    Das, A.
    Evans, T. R.
    Schellens, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
    Schlumberger, Martin
    Jarzab, Barbara
    Cabanillas, Maria E.
    Robinson, Bruce
    Pacini, Furio
    Ball, Douglas W.
    McCaffrey, Judith
    Newbold, Kate
    Allison, Roger
    Martins, Renato G.
    Licitra, Lisa F.
    Shah, Manisha H.
    Bodenner, Donald
    Elisei, Rossella
    Burmeister, Lynn
    Funahashi, Yasuhiro
    Ren, Min
    O'Brien, James P.
    Sherman, Steven I.
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 44 - 53
  • [8] Data-driven computational modeling to identify biomarkers of response to lenvatinib (E7080) in melanoma
    Kadowaki, Tadashi
    Funahashi, Yasuhiro
    Matsui, Junji
    Pavan, Kumar
    Sachdev, Pallavi
    O'Brien, Jim
    Xing, Heming
    McDonagh, Paul D.
    Khalil, Iya
    Kurzrock, Razelle
    Hong, David S.
    Nemunaitis, John
    CANCER RESEARCH, 2013, 73 (08)
  • [9] Effects of Ketoconazole on the Pharmacokinetics of Lenvatinib (E7080) in Healthy Participants
    Shumaker, Robert
    Aluri, Jagadeesh
    Fan, Jean
    Martinez, Gresel
    Thompson, Gary A.
    Ren, Min
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (02): : 155 - 160
  • [10] Treatment-Emergent Hypertension and Efficacy in the Phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (SELECT)
    Wirth, Lori J.
    Tahara, Makoto
    Robinson, Bruce
    Francis, Sanjeev
    Brose, Marcia S.
    Habra, Mouhammed Amir
    Newbold, Kate
    Kiyota, Naomi
    Dutcus, Corina E.
    Mathias, Elton
    Guo, Matthew
    Sherman, Steven I.
    Schlumberger, Martin
    CANCER, 2018, 124 (11) : 2365 - 2372
12345